cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Acadia Pharmaceuticals Inc
29 own
44 watching
Current Price
$15.82
$0.55
(3.6%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
3,839.92M
52-Week High
52-Week High
33.99000
52-Week Low
52-Week Low
14.65000
Average Volume
Average Volume
2.21M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization3,839.92M
icon52-Week High33.99000
icon52-Week Low14.65000
iconAverage Volume2.21M
iconDividend Yield--
iconP/E Ratio--
What does the Acadia Pharmaceuticals Inc do?
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinson's disease psychosis and the Phase II trial for the treatment of schizophrenia, as well as is in Phase II study for the treatment of Alzheimer's disease psychosis. The company has a collaboration with Allergan, Inc. for the development of product candidates related to chronic pain. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Read More
How much money does Acadia Pharmaceuticals Inc make?
News & Events about Acadia Pharmaceuticals Inc.
Business Wire
1 year ago
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at the following upcoming investor conferences: BofA Securities 2023 Health Care Conference Fireside Chat: Wednesday, May 10, 2023 at 2:20 p.m. Eastern Time in Las Vegas, NV The JMP Securities Life Sciences...
Business Wire
1 year ago
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report first quarter financial results on Monday, May 8, 2023, after the close of the U.S. financial markets. Acadias management team will also host a conference call and webcast on May 8, 2023, at 4:30 p.m. Eastern Time to...
Business Wire
1 year ago
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that four posters in Rett syndrome will be presented at the upcoming American Academy of Neurology (AAN) annual meeting, being held April 22 27, 2023 in Boston, Mass. The poster presentations include a secondary analysis reporting on the...
Business Wire
1 year ago
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that DAYBUE (trofinetide) is now available for the treatment of Rett syndrome in adult and pediatric patients two years of age and older in the United States. DAYBUE has demonstrated the potential to improve the signs and symptoms of Rett...
Business Wire
1 year ago
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the 22nd Annual Needham Virtual Healthcare conference on Tuesday, April 18, 2023 at 1:30 p.m. Eastern Time. The conference will be held virtually. A live webcast of the presentation will be accessible on the companys...
Frequently Asked Questions
Frequently Asked Questions
What is Acadia Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Acadia Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Acadia Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Acadia Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Acadia Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Acadia Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Acadia Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Acadia Pharmaceuticals Inc?
plus_minus_icon
What percentage is Acadia Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Acadia Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$15.82
$0.55
(3.6%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00